Q1 EPS Estimate for U.S. Physical Therapy Lowered by Analyst

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities researchers at William Blair cut their Q1 2025 earnings per share estimates for U.S. Physical Therapy in a research note issued to investors on Thursday, February 27th. William Blair analyst J. Haase now anticipates that the company will post earnings per share of $0.56 for the quarter, down from their previous estimate of $0.59. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q1 2025 earnings at $0.56 EPS, Q2 2025 earnings at $0.79 EPS, Q2 2025 earnings at $0.79 EPS, Q4 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $2.96 EPS and FY2025 earnings at $2.96 EPS.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The firm had revenue of $180.45 million for the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%.

Other equities research analysts also recently issued research reports about the company. JPMorgan Chase & Co. raised their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Tuesday, December 3rd. StockNews.com downgraded U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday. Barrington Research dropped their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research report on Friday. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Finally, Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their price objective for the company from $100.00 to $115.00 in a research report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $111.50.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $81.08 on Friday. The firm has a market cap of $1.22 billion, a P/E ratio of 86.26, a P/E/G ratio of 3.54 and a beta of 1.48. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63. The stock’s fifty day moving average price is $88.41 and its 200-day moving average price is $87.67.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.22%. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio is presently 95.65%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the sale, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Institutional investors have recently added to or reduced their stakes in the business. CBIZ Investment Advisory Services LLC boosted its holdings in U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after acquiring an additional 122 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of U.S. Physical Therapy in the fourth quarter worth about $39,000. Venturi Wealth Management LLC raised its stake in shares of U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after purchasing an additional 704 shares during the last quarter. KBC Group NV raised its stake in shares of U.S. Physical Therapy by 68.6% in the third quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after purchasing an additional 315 shares during the last quarter. Finally, Lazard Asset Management LLC purchased a new position in shares of U.S. Physical Therapy in the fourth quarter worth about $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.